Citius Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Citius Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Citius Pharmaceuticals Inc
Rating: 1.28700
Author: Trendlyne DVM scores

about

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products...

0.82 -0.04 (-4.65%)

75.88% Fall from 52W High

389.6K

XNAS Volume

XNAS 20 Jan, 2026 3:06 PM (EST)

Not Eligible

Expensive Valuation

16.0 / 100

Technically Neutral

35.5 / 100

No estimates available

Citius Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Citius Pharma Inc Live Stock Price Today, Share Analysis and Chart

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products...

75.88% Fall from 52W High

SWOT Analysis

Citius Pharma Inc Live Price Chart